Case Report | Open Access
Granulomatosis with Polyangiitis Localized in the Greater Omentum
Granulomatosis with polyangiitis (GPA) is known as anti-neutrophil cytoplasmic antibody- (ANCA-) associated small vessel vasculitis and typically manifests as pulmonary-renal syndrome, but the disease is not limited to pulmonary or renal systems. The inflammation can involve whole body organs. In addition, the ANCA titer does not always become positive. Here, we describe the case of a 91-year-old man who presented with umbilical pain and fever of unknown origin. Only the increased computed tomography value of the greater omentum suggested intra-abdominal inflammation; however, serological examinations, including the ANCA level, could not reveal the focus or cause of symptoms. Finally, the histopathological examination of specimens surgically excised from the greater omentum demonstrated GPA limited to the greater omentum. This report reminds physicians to consider GPA in the differential diagnosis of acute abdominal pain or fever of unknown origin.
Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease, previously known as Wegener’s granulomatosis, characterized by a pauci-immune necrotizing vasculitis of small- and medium-sized vessels that in typical cases involve the upper and lower respiratory tracts and the kidneys , although other limited involvements can be seen in some patients [2, 3]. GPA may occur at all ages, especially in the sixth and seventh decades of life. The classic triad of symptoms affects the upper respiratory tract, lungs, and kidneys, but the disease can affect any organ. Although in 80–95% of the patients the first symptoms are otorhinolaryngological manifestations of neck and head , patients may present with constitutional symptoms, including but not limited to fatigue, anorexia, and weight loss. These symptoms last for weeks to months with no evidence of specific organ involvement. On average, patients will be diagnosed within 3–12 months from the onset of symptoms, and at the time of diagnosis, more than two organ systems are involved .
The serum titer of the anti-neutrophil cytoplasmic antibody (ANCA) is known to be increased in most patients with GPA, and it is used as a biomarker. However, several patients have not demonstrated an increase in the serum ANCA titer . In this report, we described a case of ANCA-negative GPA that was limited to the greater omentum. Although rare, necrotizing vasculitis should be considered in the differential diagnosis of acute abdominal pain or fever of unknown origin.
2. Case Report
A 91-year-old man presented with abdominal pain and was followed up to 2 days. On physical examination, periumbilical tenderness was found, but there were no peritoneal irritation signs or other obvious abnormal findings of the ears, nose, or skin. The blood test results showed a high inflammatory reaction (white blood cell (WBC) count 13,800/µL; C-reactive protein (CRP) level 33.5 mg/L) and acute kidney injury (creatinine (Cre) 1.11 mg/dL). Urinalysis was normal. The chest radiography demonstrated no remarkable change. The computed tomography (CT) scan was negative for any infectious focus or other abnormal findings, such as cavitating nodules in the lungs or other site neoplasms. Antibiotics (tazobactam/piperacillin 13.5 g/day) were administered as empiric therapy.
After hospitalisation, the patient developed fever over 39°C. Results of the blood cultures and other cultivation tests were all negative, including the tuberculosis test. Additional analyses demonstrated a negative ANCA titer, proteinase 3- (PR3-) ANCA, and myeloperoxidase- (MPO-) ANCA. Two days later, the patient showed a new peritoneal irritation sign at the periumbilical and right lower abdomen. The CT scan showed an increased CT value of the greater omentum and ileocolic mesentery, and ascites (Figure 1). Blood test results showed that the inflammatory reaction was still high (WBC count 20,700/µL; CRP level 29.3 mg/L), although renal function returned to normal (Cre level 0.93 mg/dL). The antibiotics were changed (meropenem 3 g/day), but the fever and abdominal pain did not disappear, and inflammatory reaction remained at a high level.
Because there was no sign of infectious focus for fever and abdominal pain, except for an increased CT value of the omentum and ascites, examination laparotomy was planned. Laparotomy revealed diffuse redness and swelling of the greater omentum and pale haemorrhagic ascites (Figure 2). Histological examination of the resected omentum demonstrated both arteritis and more severe venulitis, focal necrotizing vasculitis of the venules, and palisading granuloma (Figures 3(a) and 3(c)).
The patient was diagnosed as having GPA based on the Chapel Hill Consensus Conference 2012 definitions  and treated with intravenous methylprednisolone pulse therapy (1000 mg/day for 3 days). Subsequently, daily prednisolone was administered, and the dose was gradually tapered to 15 mg over 1 month. The patient was discharged without relapse.
One year later, the patient did not show any symptoms, and the follow-up CT scan showed no sign of vascular inflammation.
Although GPA typically involves the upper airways, lungs, and kidneys, inflammatory destructive lesions may develop in almost all organs . Severe gastrointestinal involvement has been reported occasionally [2, 3], but most of the cases were detected by necropsy. Walton reviewed 56 autopsy cases and found focal necrotizing arteriolitis in the intestine in 24% of the cases . In most of the cases, GPA starts with nonspecific symptoms, such as fatigue, joint pains, and sinusitis. Occasionally, protracted fever without localising signs is manifested, but this is uncommon. In fact, pyrexia of unknown origin is less common in collagen vascular disease than in infectious disease. In a retrospective cohort of 857 patients, 16% had fever due to collagen vascular disease, and only 0.3% had fever secondary to GPA .
GPA is one of several vasculitides that are associated with ANCA, but it is not always associated with a positive ANCA titer. The ANCA titer becomes positive in approximately 82–94% of patients with GPA or microscopic polyangiitis patients according to the severity of the disease [10, 11]. GPA is usually associated with PR3-ANCA, and the specificity of ANCA testing can be as high as 90% in the active phase of generalised GPA . Currently, the clinical diagnosis is usually based on the presence of distinctive ANCA and biopsy of the affected organ, but in the limited type of GPA, the ANCA titer occasionally becomes negative . Positive levels of PR3-ANCA are found in only 46–70% of patients with the nonsystemic type of GPA . The limited type of GPA has been reported to be associated with Th1 lymphocyte polarisation, as opposed to the generalised form with greater Th2 lymphocyte polarisation . A biopsy is necessary to avoid overlooking ANCA-negative GPA, but over 50% of specimens may not be sufficient for making a diagnosis; thus, in some patients, repeated biopsies are necessary.
In our case, the patient presented with an atypical course of GPA. Except for fever and localized abdominal pain, the patient showed no issues of the respiratory tract or kidney. PR3-ANCA and MPO-ANCA titers were both negative. If the CT value would have shown no relevant change, it might have been difficult to plan examination laparotomy. During laparotomy, the omentum was obviously involved, and its histological examination showed necrotizing vasculitis of the venules and palisading granuloma. Because of these findings, the patient was diagnosed as having GPA classified as other single organ vasculitis according to the Chapel Hill Consensus Conference 2012 definitions .
Some reports assessed the clinical value of 18fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT imaging to initially diagnose GPA by indicating the biopsy sites [16, 17]. However, almost no literatures have mentioned how to determine the biopsy site in the limited type of GPA because most cases had positive ANCA or typical symptoms and laboratory changes in the respiratory tract or kidney. FDG-PET/CT and other investigative methods to help determine the appropriate biopsy site should be further addressed.
ANCA-negative GPA shows various responses to the medical treatment. Holle analysed 50 localized GPA patients with prospective follow-up and reported that although the rate of complete remission was 34%, the relapse rate was 46% . Among various drugs used for ANCA-negative GPA, prednisolone and cyclophosphamide are effective in some cases. As for our case, the sole administration of methylprednisolone was effective. Recently, rituximab has been reported to be able to control other cases in which these agents are ineffective [18, 19].
Although rare, necrotizing vasculitis should be considered in the differential diagnosis of acute abdominal pain or fever of unknown origin because, like in our case, an early diagnosis could contribute to not only treatment but also the prevention of severe abdominal manifestations, such as perforation or intra-abdominal bleeding.
Informed consent was obtained from the patient.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
All the authors contributed to the conception and design of the study and drafting, revision, and final approval of the submitted version.
- J. C. Jennette and R. J. Falk, “Small-vessel vasculitis,” New England Journal of Medicine, vol. 337, no. 21, pp. 1512–1523, 1997.
- S. J. Haworth and C. D. Pusey, “Severe intestinal involvement in Wegener’s granulomatosis,” Gut, vol. 25, no. 11, pp. 1296–1300, 1984.
- B. Storesund, J. T. T. Gran, and W. Koldingsnes, “Severe intestinal involvement in Wegener’s granulomatosis: report of two cases and review of the literature,” British Journal Rheumatology, vol. 37, no. 4, pp. 387–390, 1998.
- I. A. Srouji, P. Andrews, C. Edwards, and V. J. Lund, “Patterns of presentation and diagnosis of patients with Wegener’s granulomatosis, ENT aspects,” Journal of Laryngology & Otology, vol. 121, no. 7, pp. 653–658, 2007.
- N. I. Abdou, G. J. Kullman, G. S. Hoffman, G. C. Sharp, U. Specks, and T. McDonald, “Wegener’s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s,” Journal of Rheumatology, vol. 29, no. 2, pp. 309–316, 2002.
- J. Land, W. H. Abdulahad, S. Arends, J. F. Sanders, A. Stegeman, and P. Heeringa, “Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis,” PLoS One, vol. 12, no. 8, Article ID e0182549, 2017.
- C. G. M. Kallenberg, “Key advances in the clinical approach to ANCA-associated vasculitis,” Nature Reviews Rheumatology, vol. 10, no. 8, pp. 484–493, 2014.
- E.W. Walton, “Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis),” British Medical Journal, vol. 2, no. 5091, pp. 265–270, 1958.
- O. R. Sipahi, S. Senol, T. Yamazhan et al., “Pooled analysis of 857 published adult fever of unknown origin cases in Turkey between 1990–2006,” Medical Science Monitor, vol. 13, no. 7, p. CR318-322, 2007.
- L. Guillevin, B. Durand-Gasselin, R. Cevallos et al., “Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients,” Arthritis & Rheumatism, vol. 42, no. 3, pp. 421–430, 1999.
- J. D. Finkielman, A. S. Lee, A. M. Hummel et al., “ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis,” American Journal of Medicine, vol. 120, no. 7, 2007.
- J. Wojciechowska, W. Krajewski, P. Krajewski, and T. Kręcicki, “Granulomatosis with polyangiitis in otolaryngologist practice: a review of current knowledge,” Clinical and Experimental Otorhinolaryngology, vol. 9, no. 1, pp. 8–13, 2016.
- K. de Groot, D. K. Schmidt, A. C. Arlt, W. L. Gross, and E. Reinhold-Keller, “Standardized neurologic evaluations of 128 patients with Wegener’s granulomatosis,” Archives of Neurology, vol. 58, no. 8, pp. 1215–1221, 2001.
- J. U. Holle, W. L. Gross, K. Holl-Ulrich et al., “Prospective long-term follow-up of patients with localized Wegener’s granulomatosis: does it occur as persistent disease stage?” Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 1934–1939, 2010.
- E. Csernok, A. Trabandt, A. Müller et al., “Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation,” Arthritis & Rheumatism, vol. 42, no. 4, pp. 742–750, 1999.
- F. De Geeter and P. Gykiere, “(18)F-FDG PET imaging of granulomatosis with polyangiitis-Wegener’s syndrome,” Hellenic Journal of Nuclear Medicine, vol. 19, no. 1, pp. 53–56, 2015.
- M. Soussan, N. Abisror, S. Abad et al., “FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review,” Autoimmunity Reviews, vol. 13, no. 2, pp. 125–131, 2014.
- A. Khan, C. A. Lawson, M. A. Quinn, A. H. Isdale, and M. J. Green, “Successful treatment of anca-negative Wegener’s granulomatosis with rituximab,” International Journal of Rheumatology, vol. 2010, Article ID 846063, 2 pages, 2010.
- S. Ooka, A. Maeda, H. Ito, M. Omata, H. Yamada, and S. Ozaki, “Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener’s granulomatosis: a case report,” Modern Rheumatology, vol. 19, no. 1, pp. 80–83, 2009.
Copyright © 2018 Ryuji Komine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.